Fund Holdings — Kynam Capital Management, LP

Total Portfolio Value:
$928.82M
Total Bought:
$53.26M
Total Sold:
$313.67M
Net Transaction:
-$260.41M
Notable People:
Kynam Capital Management Gp,
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Celldex Therapeutics, Inc.(CLDX)6,500,0006,100,729-399,271$117.97M$124.15M13.37%+$6.17M
Vaxcyte, Inc.(PCVX)3,200,0003,071,588-128,412$120.83M$99.86M10.75%-$20.97M
Vera Therapeutics, Inc.CL A(VERA)2,400,0003,426,887+1,026,887$57.65M$80.74M8.69%+$23.09M
Syndax Pharmaceuticals, Inc.(SNDX)8,520,0008,520,0000$104.67M$79.79M8.59%-$24.88M
BioCryst Pharmaceuticals, Inc.(BCRX)8,928,5238,463,742-464,781$66.96M$75.84M8.16%+$8.87M
CG Oncology, Inc.(CGON)2,611,6622,457,667-153,995$63.96M$63.90M6.88%-$60.3K
Viridian Therapeutics, Inc.(VRDN)4,700,0004,427,927-272,073$63.36M$61.90M6.66%-$1.45M
Cogent Biosciences, Inc.(COGT)9,105,0008,492,557-612,443$54.54M$60.98M6.56%+$6.44M
Beam Therapeutics Inc.(BEAM)2,518,1702,417,647-100,523$49.18M$41.12M4.43%-$8.06M
Immunocore Holdings plcADS(IMCR)1,695,576976,267-719,309$50.31M$30.64M3.30%-$19.67M
Wave Life Sciences, Inc.SHS(WVE)4,899,4974,560,053-339,444$39.59M$29.64M3.19%-$9.95M
Travere Therapeutics, Inc.(TVTX)1,802,7501,540,691-262,059$32.31M$22.80M2.45%-$9.50M
Tyra Biosciences, Inc.(TYRA)2,406,0672,329,998-76,069$22.38M$22.30M2.40%-$78.3K
Dynavax Technologies Corp2,620,7972,145,319-475,478$33.99M$21.28M2.29%-$12.71M
Engene Holdings Inc
COM
4,994,0904,994,0900$22.37M$18.18M1.96%-$4.20M
Cullinan Therapeutics, Inc.(CGEM)2,338,6292,095,998-242,631$17.70M$15.76M1.70%-$1.95M
Nurix Therapeutics, Inc.(NRIX)800,0001,173,605+373,605$9.50M$13.37M1.44%+$3.86M
Relay Therapeutics, Inc.(RLAY)3,063,2922,887,014-176,278$8.03M$9.99M1.08%+$1.96M
Amarin Corp PlcADR0576,111+576,111$0$9.34M1.01%+$9.34M
UroGen Pharma Ltd.(URGN)25,000656,573+631,573$276.5K$9.00M0.97%+$8.72M
CytomX Therapeutics, Inc.(CTMX)02,154,413+2,154,413$0$4.89M0.53%+$4.89M
Geron Corporation(GERN)3,659,5263,456,318-203,208$5.82M$4.87M0.52%-$945.2K
Ironwood Pharmaceuticals, Inc.CL A(IRWD)5,822,9385,466,825-356,113$8.56M$3.92M0.42%-$4.64M
Caribou Biosciences, Inc.(CRBU)3,269,1473,067,774-201,373$2.99M$3.87M0.42%+$880.3K
Sutro Biopharma, Inc.(STRO)5,441,4475,088,099-353,348$3.54M$3.63M0.39%+$92.2K
Design Therapeutics, Inc.(DSGN)904,0171,029,579+125,562$3.49M$3.47M0.37%-$19.8K
Proqr Thrapeutics N VSHS EURO
SHS EURO
1,750,0001,649,462-100,538$2.33M$3.36M0.36%+$1.04M
Edgewise Therapeutics, Inc.(EWTX)0253,979+253,979$0$3.33M0.36%+$3.33M
Burning Rock Biotech LimitedADS(BNR)994,883994,8830$4.38M$3.14M0.34%-$1.24M
Liquidia Corporation(LQDA)633,802200,047-433,755$9.35M$2.49M0.27%-$6.86M
Climb Bio, Inc.(CLYM)1,047,0001,028,341-18,659$1.28M$1.28M0.14%-$2.2K
Amarin Corp PlcADR12,414,6280-12,414,628$5.56M$0—-$5.56M
Legend Biotech CorporationADS(LEGN)610,0000-610,000$20.70M$0—-$20.70M
Natera, Inc.(NTRA)1,167,5700-1,167,570$165.11M$0—-$165.11M
Page 1 of 1
Kynam Capital Management, LP — 13F Holdings — Q2 2025 | TickerTrail